Company intelligence / Profile preview

KES Pharma

Schleswig, Schleswig-Holstein, Germany
Ownership
Private
Development stage
Other
01

Overview

KES Pharma is a Germany-based pharmaceutical company focused on the trade and export of medicines and on commercialization of topical healthcare and cosmeceutical products. Publicly available evidence indicates the company has worked with Phi-Stone AG to develop and market products based on tetrapodal zinc oxide, including an acne serum and wound-related applications. The business appears to operate primarily as a commercial-stage distributor and product marketer rather than a clinical-stage drug developer. Its known footprint is centered in Schleswig, Germany, with Dr. Kan Fu identified as a key executive contact. Overall, KES Pharma looks like a small, active healthcare company with limited disclosed pipeline depth but some differentiated product positioning through partner-sourced materials science technology.

Therapeutic areas
DermatologyInfectious Diseases
Modalities
Topical therapyMedical deviceCosmeceutical
Industry
Consumable Medical Devices
02

Partnerships

Phi-Stone AGAbnoba

Beyond the preview

Go deeper on KES Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KES Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call